PRKN and asthma: This study is the first to identify a hitherto uncharacterized mechanism, i.e. the DEK/ATAD3A/DRP1 signaling axis, by which DEK promotes PINK1-Parkin mitophagy, NLRP3 inflammasome activation, and aggravates airway inflammation in asthma.